about
METastasis Reporting and Data System for Prostate Cancer: Practical Guidelines for Acquisition, Interpretation, and Reporting of Whole-body Magnetic Resonance Imaging-based Evaluations of Multiorgan Involvement in Advanced Prostate Cancer.Local staging of penile cancer using magnetic resonance imaging with pharmacologically induced penile erection.US-guided transcutaneous tru-cut biopsy of laryngo-hypopharyngeal lesions.Comparison of whole-body diffusion-weighted magnetic resonance and FDG-PET/CT in the assessment of Hodgkin's lymphoma for staging and treatment response.Breast MR with special focus on DW-MRI and DCE-MRIDW-MRI of the urogenital tract: applications in oncology.Perfusion CT is a valuable diagnostic method for prostate cancer: a prospective study of 94 patients.Correlation between CT perfusion and clinico-pathological features in prostate cancer: a prospective study.CT perfusion in oncology: how to do it.Perfusion CT in solid body-tumours. Part II: Clinical applications and future development.Small colorectal cystic metastases to the liver: still a diagnostic dilemma? A report of a case and a review of the literature.Salvage therapy of intraprostatic failure after radical external-beam radiotherapy for prostate cancer: a review.Salvage therapy of small volume prostate cancer nodal failures: a review of the literature.Rationale and protocol of AIRC IG-13218, short-term radiotherapy for early prostate cancer with concomitant boost to the dominant lesion.Sarcoidosis with bone involvement mimicking metastatic disease at (18)F-FDG PET/CT: problem solving by diffusion whole-body MRI.Whole body MRI for systemic staging of breast cancer in pregnant women.Primary focal prostate radiotherapy: Do all patients really need whole-prostate irradiation?Multiparametric magnetic resonance imaging and frozen-section analysis efficiently predict upgrading, upstaging, and extraprostatic extension in patients undergoing nerve-sparing robotic-assisted radical prostatectomy.Role of Multi-Parametric Magnetic Resonance Image and PIRADS Score in Patients with Prostate Cancer Eligible for Active Surveillance According PRIAS Criteria.Signal intensity change on unenhanced T1-weighted images in dentate nucleus and globus pallidus after multiple administrations of gadoxetate disodium: an intraindividual comparative study.Predicting Pathological Features at Radical Prostatectomy in Patients with Prostate Cancer Eligible for Active Surveillance by Multiparametric Magnetic Resonance Imaging.Contrast-enhanced ultrasound sonography optimises the assessment of lymph nodes in oncologyCombined ultrasmall superparamagnetic particles of iron oxide-enhanced and diffusion-weighted magnetic resonance imaging facilitates detection of metastases in normal-sized pelvic lymph nodes of patients with bladder and prostate cancer.CT perfusion in solid-body tumours. Part I: Technical issues.Capecitabine initially concomitant to radiotherapy then perioperatively administered in locally advanced rectal cancer.Baseline Multiparametric MRI for Selection of Prostate Cancer Patients Suitable for Active Surveillance: Which Features Matter?Multimodal image registration for the identification of dominant intraprostatic lesion in high-precision radiotherapy treatments.Intraobserver and interobserver variability in the calculation of apparent diffusion coefficient (ADC) from diffusion-weighted magnetic resonance imaging (DW-MRI) of breast tumours.Sclerosing angiomatoid nodular transformation of the spleen during pregnancy: Diagnostic challenges and clinical management.Rationale for Modernising Imaging in Advanced Prostate Cancer.Magnetic Resonance Imaging Before Prostate Biopsy: Time to Talk.CT perfusion for the monitoring of neoadjuvant chemotherapy and radiation therapy in rectal carcinoma: initial experienceWhole-Body Magnetic Resonance Imaging in Oncology: Uses and IndicationsThe added value of whole-body magnetic resonance imaging in the management of patients with advanced breast cancerIntra- and Interobserver Agreement and Impact of Arterial Input Selection in Perfusion CT Measurements Performed in Squamous Cell Carcinoma of the Upper Aerodigestive TractPerfusion Computed Tomography for Monitoring Induction Chemotherapy in Patients With Squamous Cell Carcinoma of the Upper Aerodigestive TractRe-irradiation for isolated local recurrence of prostate cancer: MONO-INSTITUTIONAL series of 64 patients treated with salvage stereotactic body radiotherapy (SBRT)Whole-body magnetic resonance imaging (WB-MRI) in oncology: recommendations and key usesExtramedullary myeloid sarcoma of the breastPerfusion computed tomography in patients with hepatocellular carcinoma treated with thalidomide: initial experience
P50
Q31108842-31C8FDA6-070B-4E8E-81EA-E98FE1832AB2Q33334473-F3A73122-7C1D-47A9-BF7A-CCB739CEB1B7Q33519094-54847C52-5C65-4243-AB2D-D4AB25DBBB78Q33636842-635C2060-BE41-4A60-B829-6D0D34C7DCE3Q33965703-44E53F9C-E87A-4163-ABFB-8C27DE82A815Q34256443-017F08AC-0292-4905-B0DF-9A31BF5F76BBQ34550344-FE8B22E4-40B1-4CF0-BD03-F8D3C44737B2Q34993635-71CBD690-788C-456E-92B4-5B6A91392BA5Q37693472-45BF6E76-4C5F-42B7-9848-DDCA3423FACEQ37707171-7E7DFCC4-F55B-49B0-A1C8-2BE127FCD0BEQ37944149-484DCBCA-1552-4902-8037-2C9479F41521Q38129578-E231F812-1589-4BB3-B781-98F8FB482283Q38169396-B866CFD8-3FB1-4E45-A0D9-58141384AF75Q38388976-17C05A2B-A277-44D6-BCB7-91AA2DB91885Q38504136-E3C76EAB-A589-45A0-9892-BB8F628B462BQ38653433-3C72E635-E1CF-426D-966A-8679CBD8BE2EQ38891639-75C8FC9A-5906-45FA-A344-5DBC00BBB276Q39282130-249446BD-781B-4C5B-B433-7E6637D3D48FQ39863407-490A60C6-9622-40C5-9D13-8C15442B45C1Q40267502-CD3C1C14-4487-45DE-87D1-9B4A2C9D9A02Q40458086-55300EFA-939F-443C-ABBC-DB057C1C3A3DQ41547263-5DB3F248-A908-4C30-BAF8-82A59CE6BACAQ43407465-AEE7CFD2-3F91-4220-BAD5-B31DA366AA3AQ45412629-5A7E2E45-646E-4D81-A1DD-BFD3A86DCC7DQ46124859-58B18DA1-E3CB-4D33-8113-984EBF6D27A5Q47378388-3C3F1DDF-F1EA-4001-A2EA-ADB63CEE2F4EQ52936169-E6F3A55C-5658-465A-A45B-FFFADA5B2E8DQ53079012-50D0C1B6-AC78-4FA3-955F-455397862F1FQ53101644-489CD5E8-5A02-4A07-BA0B-0719C2BE1FFAQ53136945-847F64F0-F31D-4986-A7CF-FE518BCCBFE1Q53382993-936594E5-38FE-4D8C-ADAA-2D33A974E0B5Q56786000-E8F1410B-5A0C-49C0-928B-1DE10055AAC3Q57455892-A435A640-2B5C-4531-9335-4FB1C94CF3CDQ57472254-BB22454D-70D4-42F7-AB7A-B8E0A3E49218Q57830528-31472D7C-C9B1-437F-8C2D-4F2D23D5CEA4Q58003724-1BE51D1A-7137-4E72-AEE7-63FD6E121A8BQ58086914-1DCC912B-E8DA-4506-890D-BADBB07775A2Q60714624-EB955651-3D49-4D7E-BC57-88F547848DBFQ81798500-086E46D6-42AF-4AE2-B9E1-6668CC86241FQ83632425-FA897234-1F99-4289-9AFC-0D59291FC745
P50
description
investigador
@es
researcher
@en
wetenschapper
@nl
name
Giuseppe Petralia
@en
Giuseppe Petralia
@nl
type
label
Giuseppe Petralia
@en
Giuseppe Petralia
@nl
prefLabel
Giuseppe Petralia
@en
Giuseppe Petralia
@nl
P31
P496
0000-0003-3502-3643